These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 35136060)
1. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. Liu S; Paknejad N; Zhu L; Kihara Y; Ray M; Chun J; Liu W; Hite RK; Huang XY Nat Commun; 2022 Feb; 13(1):731. PubMed ID: 35136060 [TBL] [Abstract][Full Text] [Related]
2. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer. Peyruchaud O Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039 [TBL] [Abstract][Full Text] [Related]
3. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes. Noh SJ; Kim MJ; Shim S; Han JK J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008 [TBL] [Abstract][Full Text] [Related]
5. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells. Itoh R; Miura S; Takimoto A; Kondo S; Sano H; Hiraki Y J Bone Miner Metab; 2010 Nov; 28(6):659-71. PubMed ID: 20458606 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. Chun J; Giovannoni G; Hunter SF Drugs; 2021 Feb; 81(2):207-231. PubMed ID: 33289881 [TBL] [Abstract][Full Text] [Related]
7. A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay. Fleming JK; Glass TR; Lackie SJ; Wojciak JM J Lipid Res; 2016 Sep; 57(9):1737-47. PubMed ID: 27444045 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia. Rahaman M; Costello RW; Belmonte KE; Gendy SS; Walsh MT Am J Respir Cell Mol Biol; 2006 Feb; 34(2):233-41. PubMed ID: 16224106 [TBL] [Abstract][Full Text] [Related]
9. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors. Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399 [TBL] [Abstract][Full Text] [Related]
10. Cell surface receptors in lysophospholipid signaling. Anliker B; Chun J Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. Goetzl EJ; Kong Y; Mei B J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477 [TBL] [Abstract][Full Text] [Related]
12. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells. Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. Im DS Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877 [TBL] [Abstract][Full Text] [Related]
14. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor. Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705 [TBL] [Abstract][Full Text] [Related]
15. A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors. Cheng L; Su L; Tian X; Xia F; Zhao C; Yan W; Shao Z J Vis Exp; 2022 Jun; (184):. PubMed ID: 35758708 [TBL] [Abstract][Full Text] [Related]
16. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480 [TBL] [Abstract][Full Text] [Related]
17. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. Lee CW; Rivera R; Dubin AE; Chun J J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850 [TBL] [Abstract][Full Text] [Related]
18. Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition. Yuan Y; Jia G; Wu C; Wang W; Cheng L; Li Q; Li Z; Luo K; Yang S; Yan W; Su Z; Shao Z Cell Res; 2021 Dec; 31(12):1263-1274. PubMed ID: 34526663 [TBL] [Abstract][Full Text] [Related]
19. Structural insights into sphingosine-1-phosphate receptor activation. Yu L; He L; Gan B; Ti R; Xiao Q; Hu H; Zhu L; Wang S; Ren R Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117716119. PubMed ID: 35412894 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. Rao TS; Lariosa-Willingham KD; Lin FF; Palfreyman EL; Yu N; Chun J; Webb M Brain Res; 2003 Nov; 990(1-2):182-94. PubMed ID: 14568343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]